Skip to main content
. 2019 Jul 10;9:624. doi: 10.3389/fonc.2019.00624

Table 4.

Overall response.

Best Response, n (%) Total (N = 25)
Partial response 1 (4)
Stable Disease 14 (56)
Progressive Disease 7 (28)
Unevaluable 3 (12)
Overall Response Rate (all pts) 1 of 25 patients (4%)
Overall Response Rate (evaluable pts only) 1 of 22 patients (5%)